| - GRCh37:
- Chr13:32905048
- GRCh38:
- Chr13:32330911
| BRCA2 | | Neoplasm of ovary | Uncertain significance (Sep 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47641498
- GRCh38:
- Chr2:47414359
| MSH2 | D229Y, D295Y | Neoplasm of ovary, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Jul 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:41275805
- GRCh38:
- Chr3:41234314
| CTNNB1, LOC126806659 | | Pilomatrixoma, Exudative vitreoretinopathy 7, Neoplasm of ovary, Colorectal cancer, Medulloblastoma, Severe intellectual disability-progressive spastic diplegia syndrome, Hepatocellular carcinoma, not provided | Benign/Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:41275676
- GRCh38:
- Chr3:41234185
| CTNNB1, LOC126806659 | H517R, H524R | not provided, Severe intellectual disability-progressive spastic diplegia syndrome, Hepatocellular carcinoma, Colorectal cancer, Pilomatrixoma, Exudative vitreoretinopathy 7, Neoplasm of ovary, Medulloblastoma | Uncertain significance (Nov 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162475190
- GRCh38:
- Chr6:162054158
| PRKN | D184V | Lung cancer, Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2, not provided | Uncertain significance (Sep 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162864440
- GRCh38:
- Chr6:162443408
| PRKN | Q25* | Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer, not provided | Pathogenic/Likely pathogenic (May 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162683814-162683815
- GRCh38:
- Chr6:162262782-162262783
| PRKN | | not provided, Lung cancer, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary | Benign (Sep 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:68849589
- GRCh38:
- Chr16:68815686
| CDH1 | D437N, D498N | not provided, Familial cancer of breast, Blepharocheilodontic syndrome 1, Endometrial carcinoma, Hereditary diffuse gastric adenocarcinoma, Neoplasm of ovary, Malignant tumor of prostate, Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma
| Uncertain significance (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:41246352-41246353
- GRCh38:
- Chr17:43094335-43094336
| BRCA1 | | Familial cancer of breast, Neoplasm of ovary | Pathogenic (Mar 19, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108098332-108236255
| ATM | | Acquired polycythemia vera, Endometrial serous adenocarcinoma, Neoplasm of ovary
| Pathogenic (Mar 19, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577127
- GRCh38:
- Chr17:7673809
| TP53 | E112*, E139*, E232*, E271* | Hereditary cancer-predisposing syndrome | Pathogenic (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:162683750
- GRCh38:
- Chr6:162262718
| PRKN | | Neoplasm of ovary, Lung cancer, Autosomal recessive juvenile Parkinson disease 2, not provided | Likely benign (Apr 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7572991
- GRCh38:
- Chr17:7669673
| TP53 | K214fs, K241fs, K334fs, K373fs | Li-Fraumeni syndrome | Uncertain significance (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:33433407
- GRCh38:
- Chr17:35106388
| RAD51D, RAD51L3-RFFL | Q192*, Q212*, Q80* | Hereditary cancer-predisposing syndrome | Pathogenic (Nov 10, 2020) | criteria provided, single submitter |
| | BRCA1 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| | BRCA1 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr16:23646869
- GRCh38:
- Chr16:23635548
| PALB2 | T333N | Neoplasm of ovary, Familial cancer of breast | Uncertain significance (Oct 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162683616
- GRCh38:
- Chr6:162262584
| PRKN | G118A | not provided, Neoplasm of ovary, Lung cancer, Autosomal recessive juvenile Parkinson disease 2 | Uncertain significance (Feb 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:56774284
- GRCh38:
- Chr17:58696923
| RAD51C | | Neoplasm of ovary | Uncertain significance (Jan 29, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr6:161771010
- GRCh38:
- Chr6:161349978
| PRKN | | Lung cancer, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2 | Uncertain significance (Nov 18, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:161770991
- GRCh38:
- Chr6:161349959
| PRKN | | Lung cancer, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2 | Uncertain significance (Sep 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162683722
- GRCh38:
- Chr6:162262690
| PRKN | T83A | Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2, Lung cancer, not provided, Autosomal recessive juvenile Parkinson disease 2 | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162683593-162683632
- GRCh38:
- Chr6:162262561-162262600
| PRKN | P113fs | Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer, not provided | Pathogenic/Likely pathogenic (Mar 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:56770067-56770068
- GRCh38:
- Chr17:58692706-58692707
| RAD51C | V25fs | Fanconi anemia complementation group O | Pathogenic (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:41274905
- GRCh38:
- Chr3:41233414
| CTNNB1 | | not provided, Neoplasm of ovary, Colorectal cancer, Pilomatrixoma, Exudative vitreoretinopathy 7, Severe intellectual disability-progressive spastic diplegia syndrome, Medulloblastoma, Hepatocellular carcinoma | Benign/Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162683693
- GRCh38:
- Chr6:162262661
| PRKN | | not provided, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer | Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162394354
- GRCh38:
- Chr6:161973322
| PRKN | | not provided, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer | Benign/Likely benign (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162206838
- GRCh38:
- Chr6:161785806
| PRKN | | Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer, not provided | Likely benign (Jun 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:162206876
- GRCh38:
- Chr6:161785844
| PRKN | Y239H, Y118H, Y267H | Lung cancer, Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2, not provided | Uncertain significance (Dec 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:41243779-41243797
- GRCh38:
- Chr17:43091762-43091780
| BRCA1, LOC126862571 | C1204fs, C1251fs, C1123fs, C1139fs, C1162fs, C1183fs, C1225fs, C1083fs, C1181fs, C1210fs, C1124fs, C1163fs, C1184fs, C1203fs, C1209fs, C1250fs, C955fs, C1140fs, C1180fs, C1224fs, C1248fs, C383fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr13:32893345-32893363
- GRCh38:
- Chr13:32319208-32319226
| BRCA2 | R67fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr13:32911694-32911737
- GRCh38:
- Chr13:32337557-32337600
| BRCA2 | V1068fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:41245693
- GRCh38:
- Chr17:43093676
| BRCA1 | H619fs, H572fs, H451fs, H549fs, H571fs, H592fs, H593fs, H492fs, H507fs, H508fs, H552fs, H578fs, H323fs, H530fs, H531fs, H551fs, H577fs, H616fs, H618fs, H491fs, H548fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:48023149-48023157
- GRCh38:
- Chr2:47796010-47796018
| MSH6 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr5:56167842
- GRCh38:
- Chr5:56872015
| MAP3K1 | H470fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr10:89692974-89692975
- GRCh38:
- Chr10:87933217-87933218
| PTEN | Y155fs, Y328fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:48027223-48027224
- GRCh38:
- Chr2:47800084-47800085
| MSH6 | L571fs, L399fs, L701fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:59820374
- GRCh38:
- Chr17:61743013
| BRIP1 | Q793H | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr13:32913385-32913428
- GRCh38:
- Chr13:32339248-32339291
| BRCA2 | S1632fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr10:89653804
- GRCh38:
- Chr10:87894047
| PTEN | M35fs, M208fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578478-7578480
- GRCh38:
- Chr17:7675160-7675162
| TP53 | P20fs, P113fs, P152fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577522
- GRCh38:
- Chr17:7674204
| TP53 | I122fs, I254fs, I215fs, I95fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7576913
- GRCh38:
- Chr17:7673595
| TP53 | N179fs, N311fs, N152fs, N272fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579592
- GRCh38:
- Chr17:7676274
| TP53 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578493
- GRCh38:
- Chr17:7675175
| TP53 | W107*, W14*, W146* | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Pathogenic (Sep 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579361
- GRCh38:
- Chr17:7676043
| TP53 | F109C, F70C | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7576865-7576866
- GRCh38:
- Chr17:7673547-7673548
| TP53 | Y168fs, Y195fs, Y327fs, Y288fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577029-7577030
- GRCh38:
- Chr17:7673711-7673712
| TP53 | S171fs, S303fs, S264fs, S144fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7574030-7574031
- GRCh38:
- Chr17:7670712-7670713
| TP53 | I293fs, I173fs, I200fs, I332fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7574024-7574055
- GRCh38:
- Chr17:7670706-7670737
| TP53 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578475
- GRCh38:
- Chr17:7675157
| TP53 | P152fs, P20fs, P113fs | Li-Fraumeni syndrome | Pathogenic (Oct 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577130
- GRCh38:
- Chr17:7673812
| TP53 | F138L, F231L, F270L, F111L | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Conflicting interpretations of pathogenicity (Jul 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7579307
- GRCh38:
- Chr17:7675989
| TP53 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577141
- GRCh38:
- Chr17:7673823
| TP53 | G266fs, G134fs, G227fs, G107fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578385
- GRCh38:
- Chr17:7675067
| TP53 | C50fs, C23fs, C182fs, C143fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578189
- GRCh38:
- Chr17:7674871
| TP53 | Y181*, Y220*, Y88*, Y61* | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578534
- GRCh38:
- Chr17:7675216
| TP53 | K132N, K93N | not provided, Li-Fraumeni syndrome | Pathogenic/Likely pathogenic (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577566-7577567
- GRCh38:
- Chr17:7674248-7674249
| TP53 | N80*, N200*, N107*, N239* | Li-Fraumeni syndrome | Pathogenic (Jun 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578419
- GRCh38:
- Chr17:7675101
| TP53 | E132*, E171*, E39*, E12* | Li-Fraumeni syndrome | Pathogenic (Dec 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577570
- GRCh38:
- Chr17:7674252
| TP53 | M105I, M198I, M237I, M78I | Hereditary cancer-predisposing syndrome | Likely pathogenic (Jan 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578290
- GRCh38:
- Chr17:7674972
| TP53 | | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome | Pathogenic (Nov 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578463
- GRCh38:
- Chr17:7675145
| TP53 | R117P, R156P, R24P | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576900-7576909
- GRCh38:
- Chr17:7673582-7673591
| TP53 | S181fs, S274fs, S154fs, S313fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7576852
- GRCh38:
- Chr17:7673534
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578379
- GRCh38:
- Chr17:7675061
| TP53 | D184fs, D52fs, D145fs, D25fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578239-7578240
- GRCh38:
- Chr17:7674921-7674922
| TP53 | E204*, E45*, E72*, E165* | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577046-7577050
- GRCh38:
- Chr17:7673728-7673732
| TP53 | H257fs, H137fs, H164fs, H296fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579419-7579420
- GRCh38:
- Chr17:7676101-7676102
| TP53 | S51fs, S90fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578195-7578197
- GRCh38:
- Chr17:7674877-7674879
| TP53 | V59del, V218del, V86del, V179del | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578456-7578459
- GRCh38:
- Chr17:7675138-7675141
| TP53 | R158fs, R26fs, R119fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578402-7578404
- GRCh38:
- Chr17:7675084-7675086
| TP53 | C17R, C44R, C137R, C176R | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579434-7579441
- GRCh38:
- Chr17:7676116-7676123
| TP53 | A83fs, A44fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578259
- GRCh38:
- Chr17:7674941
| TP53 | V158E, V197E, V65E, V38E | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577586
- GRCh38:
- Chr17:7674268
| TP53 | I100S, I193S, I232S, I73S | Hereditary cancer-predisposing syndrome | Pathogenic (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577082
- GRCh38:
- Chr17:7673764
| TP53 | E154*, E247*, E286*, E127* | Li-Fraumeni syndrome | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578188
- GRCh38:
- Chr17:7674870
| TP53 | E182*, E221*, E89*, E62* | Li-Fraumeni syndrome | Pathogenic (Jul 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579346
- GRCh38:
- Chr17:7676028
| TP53 | L114*, L75* | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7578176
- GRCh38:
- Chr17:7674858
| TP53 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7573993-7574000
- GRCh38:
- Chr17:7670675-7670682
| TP53 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579417-7579427
- GRCh38:
- Chr17:7676099-7676109
| TP53 | P87fs, P48fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577128
- GRCh38:
- Chr17:7673810
| TP53 | F138fs, F231fs, F111fs, F270fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579462-7579463
- GRCh38:
- Chr17:7676144-7676145
| TP53 | A37fs, A76fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577098
- GRCh38:
- Chr17:7673780
| TP53 | R148S, R241S, R280S, R121S | Hereditary cancer-predisposing syndrome | Uncertain significance (May 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:56809906
- GRCh38:
- Chr17:58732545
| RAD51C | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:47705467-47705468
- GRCh38:
- Chr2:47478328-47478329
| MSH2 | | Hereditary cancer-predisposing syndrome | Pathogenic (Oct 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:41243455
- GRCh38:
- Chr17:43091438
| LOC126862571, BRCA1 | L1365V, L1318V, L1277V, L1297V, L1338V, L1069V, L1237V, L1253V, L1294V, L1323V, L497V, L1254V, L1298V, L1324V, L1362V, L1197V, L1238V, L1276V, L1295V, L1317V, L1339V, L1364V | Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Mar 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:41245645-41245646
- GRCh38:
- Chr17:43093628-43093629
| BRCA1 | N588*, N635*, N339*, N467*, N507*, N508*, N594*, N608*, N609*, N634*, N546*, N564*, N567*, N587*, N523*, N565*, N568*, N593*, N632*, N524*, N547* | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| | BRCA1 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| | BRCA1 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| | BRCA1 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:41256234
- GRCh38:
- Chr17:43104217
| BRCA1 | E116*, E69*, E46*, E72*, E90*, E113* | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:48026613-48026641
- GRCh38:
- Chr2:47799474-47799502
| MSH6 | K196fs, K498fs, K368fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr10:89725051-89725067
- GRCh38:
- Chr10:87965294-87965310
| PTEN | L148fs, L345fs, L518fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:215645284
- GRCh38:
- Chr2:214780560
| BARD1 | K438N, K419N | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:41246246-41246247
- GRCh38:
- Chr17:43094229-43094230
| BRCA1 | S434fs, S387fs, S307fs, S323fs, S346fs, S392fs, S407fs, S408fs, S138fs, S363fs, S366fs, S367fs, S364fs, S386fs, S431fs, S266fs, S306fs, S322fs, S345fs, S393fs, S433fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:33434384
- GRCh38:
- Chr17:35107365
| RAD51D, RAD51L3-RFFL | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr5:56177536-56177547
- GRCh38:
- Chr5:56881709-56881720
| MAP3K1 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:48027958
- GRCh38:
- Chr2:47800819
| MSH6 | E946*, E816*, E644* | Hereditary cancer-predisposing syndrome | Pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr13:32971183
- GRCh38:
- Chr13:32397046
| BRCA2 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:41244452
- GRCh38:
- Chr17:43092435
| BRCA1 | E986fs, E1033fs, E1006fs, E906fs, E965fs, E966fs, E944fs, E962fs, E1032fs, E737fs, E905fs, E921fs, E963fs, E985fs, E1007fs, E1030fs, E865fs, E922fs, E945fs, E991fs, E992fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |